LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Benamer, Hani (2006)
Publisher: CoAction Publishing
Journal: The Libyan Journal of Medicine
Languages: English
Types: Article
Subjects: ABC Article, Restless legs syndrome, dopamine agonists

Classified by OpenAIRE into

mesheuropmc: mental disorders, body regions, nervous system diseases
Up to 15% of the adult population experiences restless legs syndrome, or Ekbom syndrome during their life [1]. The patients may present to a wide range of medical specialities such as general practitioners, general physicians, nephrologists, haematologists, obstetricians, endocrinologists, rheumatologists, and neurologists. Around 3% of patients experience major sleep disturbance that needs active medical treatment [2,3]. Therefore, knowing about Restless Legs Syndrome (RLS) is vital to provide a proper diagnosis and treatment to patients with this condition.

Share - Bookmark

Cite this article